KEY FEATURES
| Full Name | Heparan Sulfate Proteoglycan |
|---|---|
| Synonym | SDC2; HSPG1; SYND2; Fibroglycan; Syndecan 2; Syndecan Proteoglycan 2; Heparan Sulfate Proteoglycan 1,Cell Surface-Associated; Heparan Sulphate Proteoglycan |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 15.6-1000pg/mL |
| Sensitivity | 6.4pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human HSPG in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human HSPG. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human HSPG and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human HSPG, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human HSPG. You can calculate the concentration of Human HSPG in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human HSPG ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 52.99 | 114.3 | 433.64 | 57.32 | 118.29 | 448.5 |
| Standard deviation | 2.68 | 6.61 | 17.09 | 3.49 | 7.06 | 16.5 |
| CV(%) | 5.05 | 5.78 | 3.94 | 6.08 | 5.97 | 3.68 |
RECOVERY
The recovery of Human HSPG spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 84-98 | 90 |
| EDTA plasma (n=8) | 87-100 | 94 |
| Cell culture media (n=8) | 84-96 | 91 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human HSPG in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with HSPG2 ELISA Kits
| SDC2 ELISA Kit | publications with HSPG2 and SDC2 |
| HPSE ELISA Kit | publications with HSPG2 and HPSE |
| BGN ELISA Kit | publications with HSPG2 and BGN |
| APP ELISA Kit | publications with HSPG2 and APP |
Pathways associated with HSPG2 ELISA Kit
| A Tetrasaccharide Linker Sequence Is Required For GAG Synthesis Pathway | A Tetrasaccharide Linker Sequence Is Required For GAG Synthesis Pathway |
| Amyloids Pathway | Amyloids Pathway |
| Chondroitin Sulfate/dermatan Sulfate Metabolism Pathway | Chondroitin Sulfate/dermatan Sulfate Metabolism Pathway |
| Chylomicron-mediated Lipid Transport Pathway | Chylomicron-mediated Lipid Transport Pathway |
| Disease Pathway | Disease Pathway |
| Diseases Associated With Visual Transduction Pathway | Diseases Associated With Visual Transduction Pathway |
| ECM-receptor Interaction Pathway | ECM-receptor Interaction Pathway |
| Extracellular Matrix Organization Pathway | Extracellular Matrix Organization Pathway |
| Glycosaminoglycan Metabolism Pathway | Glycosaminoglycan Metabolism Pathway |
Diseases associated with HSPG2 ELISA Kit
| Nervous System Diseases | publications with HSPG2 and Nervous System Diseases |
| Osteochondrodysplasias | publications with HSPG2 and Osteochondrodysplasias |
| Mental Disorders | publications with HSPG2 and Mental Disorders |
| Disease Models, Animal | publications with HSPG2 and Disease Models, Animal |
| Movement Disorders | publications with HSPG2 and Movement Disorders |
| Kidney Diseases | publications with HSPG2 and Kidney Diseases |
| Dementia | publications with HSPG2 and Dementia |
| Alzheimer Disease | publications with HSPG2 and Alzheimer Disease |
| Dyssegmental dysplasia | publications with HSPG2 and Dyssegmental dysplasia |
| Congenital Abnormalities | publications with HSPG2 and Congenital Abnormalities |
Organs/Tissues associated with HSPG2 ELISA Kit
| Blood | publications with HSPG2 and Blood |
| Bone | publications with HSPG2 and Bone |
| Muscle | publications with HSPG2 and Muscle |
| Vascular | publications with HSPG2 and Vascular |
| Embryonic Tissue | publications with HSPG2 and Embryonic Tissue |
| Connective Tissue | publications with HSPG2 and Connective Tissue |
| Eye | publications with HSPG2 and Eye |
| Brain | publications with HSPG2 and Brain |
| Ovary | publications with HSPG2 and Ovary |
| Kidney | publications with HSPG2 and Kidney |